Whose price is on this row
The figures recorded here are what the manufacturer's delivery pharmacy charges a self-pay buyer. PlushCare publishes them on its own page, states that the vials are available through that pharmacy for cash-pay buyers, and names a retail chain as an alternative pickup point.
PlushCare's own money is elsewhere. A monthly membership, with the first month free, and a separate visit fee for an initial appointment without insurance. Those are recorded on this row as a membership rather than as a medication price, which is what they are.
So a year here is three lines on a statement, and only one of them is on the comparison table's headline figure. Read the qualifier printed beside each price on this page — it names the dispensing party, and that is the whole point of the row.
The medication ladder is published properly
The vial route is priced by dose strength: a lower figure at the starting dose, a middle one, and a third covering the top of the range. The pen route is a single flat monthly figure covering every dose.
That is a real disclosure. Most sellers publish a starting-at figure and let a reader discover the ladder at titration. Here both the shape of the ladder and the flat alternative are on one page, so the arithmetic for a year can be done before anything is bought.
One condition travels with it: the page states that refills must be purchased within a set number of days of the previous delivery. A self-pay programme with a refill window is a programme you can fall out of by being late, and that is worth knowing before the first fill rather than after the third.
No compounded product at all
Eight of the sixty-five sellers here publish brand-name prices and no compounded price, and this is one of them. Everything on offer is an FDA-approved finished drug, and there is no compounded lane hidden behind an intake.
For a reader who has decided against compounded preparations, that removes the largest question in this category outright. It also means the medication bill is what an approved drug costs without insurance, which is a different order of number from most of this roster.
A third figure on the same page describes the retail cost of the pens without insurance. That is a market reference, not a PlushCare price and not the self-pay price, and it is not recorded here. A page carrying three numbers about one product is a page to read slowly.
What PlushCare charges for itself
The membership is billed monthly with the first month free, and the initial visit without insurance is charged separately. The page also states that most patients with in-network insurance pay far less for a visit, which is the only place insurance enters this row at all.
A free first month is a discount, not a price. The advertised entry cost of the membership is therefore not what a second month costs, and this roster records the ongoing rate with the free month noted beside it.
Twenty of the sixty-five sellers here bill a membership apart from the medication. This one is unusual in that the medication is not billed by it either, so the split is three ways rather than two.
What is missing, and one thing that is hidden
No list of served states appears on the weight page, the medication page or the terms. Thirty-three of the sixty-five sellers here publish none, so the silence is ordinary, and it still has to be resolved before you plan around it.
No individual prescribing clinician is named. The corporate disclosure is unusually complete — the operating company, its corporate parent and the date of the acquisition are all in the terms — but the clinical disclosure stops at a description of the physician-owned practices that deliver care.
Two elements on the weight page compute to hidden while still occupying real space on the layout, and one of them describes a cash-pay home-delivery option at a figure lower than anything recorded here. No control on the page revealed it, so it is not recorded. It is unread rather than absent, and anyone walking the intake should look for it.
PlushCare's published pricing
| Medication | Price | Verified |
|---|---|---|
| Tirzepatide (brand) | $299/moSelf-pay only, dispensed and billed by LillyDirect rather than by PlushCare, and covering every dose strength at three prices: "Zepbound® Vials · LillyDirect home delivery pharmacy · Covers every dose strength (2.5 mg–15 mg) · $299 (2.5 mg), $399 (5 mg), $449 (7.5 mg–15 mg) per month". PlushCare's own membership and visit fee are charged on top. | September 2026source |
| Tirzepatide (brand) | $449/moThe top of the same published vial ladder — "$449 (7.5 mg–15 mg) per month" — dispensed and billed by LillyDirect, with PlushCare's membership and visit fee on top. Refills "must be purchased within 45 days of the prior delivery/receipt date". | September 2026source |
| Tirzepatide (brand) | $650/moA flat rate for the pen presentation, dispensed and billed by LillyDirect: "Zepbound® Pens · LillyDirect home delivery pharmacy · Flat $650 monthly self-pay price · New pen shipped via LillyDirect". The same page separately describes the retail cost of the pens without insurance, which is not a PlushCare price and is not recorded here. | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 65 providers reviewed here are paid partners today; the other 61 are not. See how this works.
See PlushCare's current price →Good fit if
- Readers who want an FDA-approved finished drug at the manufacturer's own self-pay price and are happy to pay a care fee on top.
- Buyers who want the dispensing pharmacy named — here it is the manufacturer's own delivery service, plus a named retail chain for pickup.
- People who want the whole dose ladder and a flat pen alternative published on one page before they start.
- Readers who want an operating company, a corporate parent and an acquisition date stated in the terms.
Look elsewhere if
- Anyone looking for a single all-in charge. Here the membership, the visit and the medication are three separate bills.
- Readers who need their state confirmed before starting. No coverage list is published anywhere.
- Buyers who want a compounded option. There is none, and the approved-product figures are far higher than compounded ones elsewhere on this roster.
- People who want an individual prescribing clinician named before they pay.
How this review was verified
- Read the weight-loss page and the brand-name medication page in a browser and audited every dollar element for computed opacity, visibility and a real laid-out rectangle before recording a figure.
- Recorded the medication figures with the dispensing party named in every qualifier, because the manufacturer's delivery pharmacy sets and bills them and PlushCare does not.
- Recorded the membership with its free first month and put the separate initial-visit fee into the membership qualifier, so no single figure on this row reads as the whole bill.
- Excluded the retail cost figure printed on the same page. It is a market reference for an uninsured buyer, not this seller's price and not the self-pay one.
- Excluded two elements that compute to hidden while still occupying real space on the layout, one of which describes a lower cash-pay home-delivery figure. No control on the page revealed them, so they fail the visible-text test. They are recorded as unread rather than as absent.
- Took the terms URL from the site's own footer rather than minting one. A plausible guess at that path returns a not-found response.
- Confirmed the operating company, its corporate parent and the stated acquisition date on the terms page, and censused three pages for a state list without finding one.
- Searched the agency's published warning-letter record for the operating company and its parent, 2017 to 2026, and found nothing. That search covers warning letters only; untitled letters are published separately and were not searched.